Best GLP-1 Providers in Texas (2026)

See by medication

Looking for a specific GLP-1? Browse Texas providers by drug.

About GLP-1s in Texas

Texas has one of the largest telehealth GLP-1 markets in the country. Texas Medicaid covers GLP-1s only for type 2 diabetes diagnosis.

• •Texas's adult obesity rate is 34.0%
• •Texas Medicaid restricts GLP-1 coverage to diabetes
• •Texas is a major hub for telehealth GLP-1 provider headquarters

Top Cities for GLP-1 Treatment in Texas

Telehealth providers ship to all Texas addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Texas GLP-1 clinic directory →

GLP-1 Care Access in Texas: The Numbers

Texas has 2,478 NPI-registered in-person weight-management clinics across 243 cities — 57 with an obesity-medicine taxonomy, 1,013 endocrinology, and 1,428 bariatric — alongside 105 telehealth programs that ship to Texas addresses. The cheapest verified ongoing compounded semaglutide price available to Texas residents is $66/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Texas

In Q1 2026, Texas Medicaid reimbursed approximately $54,878,987 across 50,815 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Texas cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Texas Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Texas

According to CDC data, 34% of Texas adults have obesity (BMI of 30 or higher). This places Texas at #16 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Texas residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions